Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JRM-001 Autologous Cardiac Stem Cell Therapy After Reconstructive Surgery in Pediatric Congenital Heart Disease
jRCT1080223307Phase 3Recruiting
- Sponsor
- Metcela Inc.
- Start
- Aug 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3 trial of deramiocel in Cardiovascular Malformation (CVM) (2 arms), sponsored by Metcela Inc. Started Aug 2016; status: recruiting.
02
Drugs
deramiocel
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on jRCT1080223307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223307.